Gritstone bio, Inc. (NASDAQ: GRTS) reported Q1 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.44 million versus the consensus estimate of $3.8 million.

For earnings history and earnings-related data on Gritstone bio, Inc. (GRTS) click here.